Satellite Events

Early IP decisions in medtech—what to file, what to disclose, what to keep confidential, and how to structure early claims—often determine outcomes years later in diligence, enforcement, and competitive positioning. Join us for lunch and a practical examination of how early-stage drafting and portfolio design choices quietly shape exit value, litigation leverage, and long-term competitive exposure in a regulated and design-around-prone industry.